Bio-Path (BPTH) to Release Quarterly Earnings on Friday

Bio-Path (NASDAQ:BPTH) will be posting its quarterly earnings results before the market opens on Friday, November 15th. Analysts expect Bio-Path to post earnings of ($1.02) per share for the quarter.

Bio-Path (NASDAQ:BPTH) last posted its earnings results on Thursday, August 15th. The company reported ($1.16) EPS for the quarter, topping analysts’ consensus estimates of ($1.54) by $0.38. During the same period in the previous year, the company earned ($10.60) earnings per share. On average, analysts expect Bio-Path to post $-6 EPS for the current fiscal year and $-4 EPS for the next fiscal year.

Bio-Path Stock Down 2.0 %

Shares of BPTH opened at $0.89 on Friday. The business’s 50 day simple moving average is $1.00 and its 200-day simple moving average is $1.65. Bio-Path has a 1 year low of $0.80 and a 1 year high of $12.43.

Analyst Upgrades and Downgrades

Separately, StockNews.com started coverage on shares of Bio-Path in a research report on Friday. They set a “sell” rating on the stock.

About Bio-Path

Bio-Path Holdings, Inc operates as a clinical and preclinical stage oncology focused RNAi nanoparticle drug development company in the United States. The company develops products based on DNAbilize, a drug delivery and antisense technology platform that uses P-ethoxy, which is a deoxyribonucleic acid (DNA) backbone modification intended to protect the DNA from destruction.